Ultragenyx Pharmaceutical RARE FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ultragenyx Pharmaceutical's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ultragenyx Pharmaceutical's FX effect on cash?
- Ultragenyx Pharmaceutical (RARE) reported FX effect on cash of -$1M in Q1 2026.
- How has Ultragenyx Pharmaceutical's FX effect on cash changed year-over-year?
- Ultragenyx Pharmaceutical's FX effect on cash decreased by 200.0% year-over-year, from $1M to -$1M.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.